Effects of Dietary Fiber on Gastrointestinal Function

NCT ID: NCT01495182

Last Updated: 2016-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study will be to assess the gastrointestinal effects of a dietary fiber in healthy, adult volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a blinded, cross-over design with subjects completing three, two-week treatment periods, separated by two, two-week washouts. Volunteers will consume a dietary fiber for two of the treatment periods at two dose levels. The fiber will be added to foods and dispensed to subjects to be consumed twice a day during each treatment period. During the control period, subjects will receive the same study foods, but with no added fiber. Major outcomes will include fecal weight, and responses to questionnaires that assess fecal characteristics, bowel habits and gastrointestinal tolerability.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dietary Fiber - Dose 1

Dietary fiber will be added to study foods

Group Type EXPERIMENTAL

Dietary fiber

Intervention Type OTHER

A proprietary fiber will be given to subjects

Dietary Fiber - Dose 2

Dietary fiber will be added to study foods

Group Type EXPERIMENTAL

Dietary fiber

Intervention Type OTHER

A proprietary fiber will be given to subjects

Control

Study foods with no added fiber will be given

Group Type ACTIVE_COMPARATOR

Dietary fiber

Intervention Type OTHER

A proprietary fiber will be given to subjects

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary fiber

A proprietary fiber will be given to subjects

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy men and women
* age 18 - 54 years
* BMI \< 30 kg/m2

Exclusion Criteria

* presence of GI or other serious diseases known to affect GI function
* recent use of antibiotics
* very high fiber intake
* use of medications known to affect GI function
* presence of allergies to study foods
Minimum Eligible Age

18 Years

Maximum Eligible Age

54 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ingredion Incorporated

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kevin Maki, PhD

Role: PRINCIPAL_INVESTIGATOR

Provident Clinical Research Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Provident Clinical Research and Consulting Inc

Glen Ellyn, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Elemental Diet and Gut Microbiome
NCT05978973 COMPLETED NA